K161201 is an FDA 510(k) clearance for the ClearRead CT. Classified as Lung Computed Tomography System, Computer-aided Detection (product code OEB), Class II - Special Controls.
Submitted by Riverain Technologies, LLC (Miamisburg, US). The FDA issued a Cleared decision on September 9, 2016 after a review of 134 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.
NCT02440139
Completed
Interventional
Evaluation of Computer-Aided Lung Nodule Detection Software in Thoracic CT for Riverain Technologies LLC
Computer-Aided System for the Improvement of Nodule Detection and Characterization in Thoracic CT Based on a Novel Vessel Suppressed CT Volume
| Condition studied |
Lung Cancer |
| Study design |
Parallel |
| Eligibility |
All sexes
· 55 Years+
|
| Principal investigator |
Matthew T Freedman, M.D. |
| Sponsor |
Virginia Polytechnic Institute and State University
|
Started 2015-04-01
→
Primary completion 2017-09-01
→
Completed 2018-03-01
Primary outcome
Comparing the Detection Accuracy, Sensitivity, and Specificity of Clinically Actionable Lung Nodules
Secondary outcome
Average Reading Time Per Case
View full study on ClinicalTrials.gov